EFFECT OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS ON BIOMARKERS OF CARDIAC REMODELING: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Ros, Marta Lorente
Ros, Alvaro Lorente
Romeo, Francisco Jose
Gallardo, Jose Aguilar
Mahmood, Kiran
机构：
[1] Georgetown Univ, Medstar Washington Hosp Ctr, Washington, DC USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1343-123
引用
收藏
页码：553 / 553
页数：1
相关论文
共 50 条
  • [1] Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis
    Avgerinos, Ioannis
    Karagiannis, Thomas
    Matthews, David R.
    Tsapas, Apostolos
    Bekiari, Eleni
    DIABETES OBESITY & METABOLISM, 2023, 25 (10) : 3020 - 3029
  • [2] Effect of sodium-glucose co-transporter-2 inhibitors on arterial stiffness: A systematic review and meta-analysis of randomized controlled trials
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Kassimis, George
    Fragakis, Nikolaos
    Vassilikos, Vassilios
    Karagiannis, Asterios
    Doumas, Michael
    VASCULAR MEDICINE, 2022, 27 (05) : 433 - 439
  • [3] The impact of sodium-glucose co-transporter-2 inhibitors on serum sodium and potassium in patients with Heart Failure: a systematic review and meta-analysis
    Amani-Beni, Reza
    Darouei, Bahar
    Shafie, Davood
    Mortaheb, Mohammadreza
    Malakoutikhah, Mohammadreza
    Ebrahimi, Amirhossein
    Heidari-Hasanabadi, Sara
    Rad, Mehrdad Rabiee
    Dabaghi, Ghazal Ghasempour
    Mazaheri-Tehrani, Sadegh
    Amini-Salehi, Ehsan
    Abhari, Amir Parsa
    Heidarpour, Maryam
    BMC CARDIOVASCULAR DISORDERS, 2025, 25 (01):
  • [4] A review of the safety of sodium-glucose co-transporter-2 inhibitors
    O'Hara, Daniel Vincent
    Jardine, Meg J.
    DIABETES OBESITY & METABOLISM, 2025,
  • [5] Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis
    Zheng, Hanrui
    Liu, Min
    Li, Sheyu
    Shi, Qingyang
    Zhang, Shengzhao
    Zhou, Yiling
    Su, Na
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [6] Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
    Zaccardi, F.
    Webb, D. R.
    Htike, Z. Z.
    Youssef, D.
    Khunti, K.
    Davies, M. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08) : 783 - 794
  • [7] CARDIOVASCULAR OUTCOMES WITH SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN ASIANS: AN UPDATED META-ANALYSIS
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Toumpourleka, Maria
    Koutsampasopoulos, Konstantinos
    Mavridou, Maria
    Siskos, Fotios
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2021, 39 : E176 - E177
  • [8] Meta-Analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on Pulmonary Artery Pressure Indices
    Patoulias, Dimitrios
    Doumas, Michael
    Papadopoulos, Christodoulos
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 172 : 169 - 170
  • [9] EFFECTS OF COMBINED SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS AND LOOP DIURETICS ON SYSTOLIC BLOOD PRESSURE: SYSTEMATIC REVIEW AND META-ANALYSIS
    Alshehri, Mohammed A.
    Orayj, Khalid
    JOURNAL OF HYPERTENSION, 2023, 41 : E389 - E389
  • [10] Generalizability of sodium-glucose co-transporter-2 inhibitors cardiovascular outcome trials to the type 2 diabetes population: a systematic review and meta-analysis
    Marco Castellana
    Filippo Procino
    Rodolfo Sardone
    Pierpaolo Trimboli
    Gianluigi Giannelli
    Cardiovascular Diabetology, 19
12345